Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Dickson

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Frontiers in Physiology|March 21, 2020
Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established DiseasePradeep Harish, Leysa Forrest, Shanti Herath, et al.
The Journal of Gene Medicine|September 24, 2004
Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arraysIan R Graham, Vanessa J Hill, Muthiah Manoharan, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx MiceNgoc Lu-Nguyen, Alberto Malerba, Linda Popplewell, et al.
Neurobiology of Disease|June 26, 2017
Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acidJade Marsh, Saifuddien Haji Bagol, Robin S B Williams, et al.
Journal of Neuroscience Methods|September 18, 2021
A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2Helena Chaytow, Ilda Sethw Hassan, Sara Akbar, et al.
Current Gene Therapy|November 9, 2010
Production of non viral DNA vectorsMartin Schleef, Markus Blaesen, Marco Schmeer, et al.
The Journal of Gene Medicine|September 2, 2003
Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts)Anna Manzano, Zahra Mohri, Galia Sperber, et al.
BMC Genomics|June 3, 2010
Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organizationMohammad M Ghahramani Seno, Capucine Trollet, Takis Athanasopoulos, et al.
In Vivo (Athens, Greece)|December 22, 2009
Efficient liver-directed gene transfer by in situ generation of retroviral vector from adenoviral templatesJulian D Harris, Michael L Roberts, Dhayaneethie Perumal, et al.
Human Molecular Genetics|January 21, 2016
Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approachAnne-Charlotte Marsollier, Lukasz Ciszewski, Virginie Mariot, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Frontiers in Physiology|March 21, 2020
Inhibition of Myostatin Reduces Collagen Deposition in a Mouse Model of Oculopharyngeal Muscular Dystrophy (OPMD) With Established DiseasePradeep Harish, Leysa Forrest, Shanti Herath, et al.
The Journal of Gene Medicine|September 24, 2004
Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arraysIan R Graham, Vanessa J Hill, Muthiah Manoharan, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Systemic Antisense Therapeutics for Dystrophin and Myostatin Exon Splice Modulation Improve Muscle Pathology of Adult mdx MiceNgoc Lu-Nguyen, Alberto Malerba, Linda Popplewell, et al.
Neurobiology of Disease|June 26, 2017
Synapsin I phosphorylation is dysregulated by beta-amyloid oligomers and restored by valproic acidJade Marsh, Saifuddien Haji Bagol, Robin S B Williams, et al.
Journal of Neuroscience Methods|September 18, 2021
A new strategy to increase RNA editing at the Q/R site of GluA2 AMPA receptor subunits by targeting alternative splicing patterns of ADAR2Helena Chaytow, Ilda Sethw Hassan, Sara Akbar, et al.
Current Gene Therapy|November 9, 2010
Production of non viral DNA vectorsMartin Schleef, Markus Blaesen, Marco Schmeer, et al.
The Journal of Gene Medicine|September 2, 2003
Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts)Anna Manzano, Zahra Mohri, Galia Sperber, et al.
BMC Genomics|June 3, 2010
Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organizationMohammad M Ghahramani Seno, Capucine Trollet, Takis Athanasopoulos, et al.
In Vivo (Athens, Greece)|December 22, 2009
Efficient liver-directed gene transfer by in situ generation of retroviral vector from adenoviral templatesJulian D Harris, Michael L Roberts, Dhayaneethie Perumal, et al.
Human Molecular Genetics|January 21, 2016
Antisense targeting of 3' end elements involved in DUX4 mRNA processing is an efficient therapeutic strategy for facioscapulohumeral dystrophy: a new gene-silencing approachAnne-Charlotte Marsollier, Lukasz Ciszewski, Virginie Mariot, et al.
Pageof 11